← Leaderboards
Gayatri Vedantam
Southern Arizona Va Health Care System
$2,516,089
Attributed
$2,729,526
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $426.9K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,729,526 · 5
VA$0 · 3
By mechanism
R21$1,614,316 · 4
R33$1,115,210 · 1
I01$0 · 1
IK6$0 · 2
Top collaborators
- V K Viswanathan1 shared
Others in their field
Top investigators on “Clostridium Difficile”
- Urs Ochsner · Crestone, Inc.$20,004,167
- Hanping Feng · University Of Maryland Baltimore$18,578,582
- Nasia Safdar · Wm S. Middleton Memorial Veterans Hosp$14,163,407
- William A Petri · University Of Virginia$13,916,669
- Vincent B Young · Michigan State University$12,048,959
- Robert A Britton · Baylor College Of Medicine$11,320,245
Research focus
Clostridium DifficileInfectionAntibioticsHospitalsBacteriaPathogenPreventHealthcare SystemsIntestinesEngineeringCellsBacterial InfectionsAnimalsBacterial AdhesinsProteinsToxinProbioticsCenters For Disease Control And Prevention (U.S.)Animal ModelLaboratoriesRisk FactorsEpidemicImmunityCost Effective
Grant awards (27)
Advancing a Platform Technology for C. difficile Infection Treatment: the Promise of Antisense Oligonucleotides$426,875
R21 · FY2025 · AI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
A Bio-controlled, Microbiota-Sparing, Live Biotherapeutic Anti-Infective for Clostridioides difficile$184,880
R21 · FY2023 · AI · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
A Bio-controlled, Microbiota-Sparing, Live Biotherapeutic Anti-Infective for Clostridioides difficile$223,773
R21 · FY2022 · AI · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
A safe, targeted, designer probiotic to prevent or treat C. difficile infection$379,204
R33 · FY2020 · AI · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
A safe, targeted, designer probiotic to prevent or treat C. difficile infection$376,845
R33 · FY2019 · AI · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2019 · VA · contact PI
A safe, targeted, designer probiotic to prevent or treat C. difficile infection$359,161
R33 · FY2018 · AI · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2018 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2018 · VA · contact PI
A safe, targeted, designer probiotic to prevent or treat C. difficile infection$184,516
R21 · FY2017 · AI · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2017 · VA · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2017 · VA · contact PI
A safe, targeted, designer probiotic to prevent or treat C. difficile infection$204,916
R21 · FY2016 · AI · contact PI
Redox stress responses in Clostridium difficile: mechanisms and implications$185,076
R21 · FY2016 · AI · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2016 · VA · contact PI
Redox stress responses in Clostridium difficile: mechanisms and implications$204,280
R21 · FY2015 · AI · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2015 · VA · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2014 · VA · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2013 · VA · contact PI
Gastrointestinal Colonization of Diarrheagenic Clostridium difficile$0
I01 · FY2011 · VA · contact PI